ID   EPHB1_HUMAN             Reviewed;         984 AA.
AC   P54762; A8K593; O43569; O95142; O95143; Q0VG87;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-NOV-2010, entry version 118.
DE   RecName: Full=Ephrin type-B receptor 1;
DE            EC=2.7.10.1;
DE   AltName: Full=ELK;
DE   AltName: Full=EPH-like kinase 6;
DE            Short=EK6;
DE            Short=hEK6;
DE   AltName: Full=NET;
DE   AltName: Full=Tyrosine-protein kinase receptor EPH-2;
DE   Flags: Precursor;
GN   Name=EPHB1; Synonyms=EPHT2, NET;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   MEDLINE=96115594; PubMed=8666391; DOI=10.1006/geno.1995.9985;
RA   Tang X.X., Biegel J.A., Nycum L.M., Yoshioka A., Brodeur G.M.,
RA   Pleasure D.E., Ikegaki N.;
RT   "cDNA cloning, molecular characterization, and chromosomal
RT   localization of NET(EPHT2), a human EPH-related receptor protein-
RT   tyrosine kinase gene preferentially expressed in brain.";
RL   Genomics 29:426-437(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT TRP-973.
RC   TISSUE=Kidney;
RA   Stein E., Schoecklmann H.O., Daniel T.O.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 18-32.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   INTERACTION WITH GRB2 AND GRB10, MUTAGENESIS OF TYR-928, AND
RP   PHOSPHORYLATION AT TYR-928.
RX   MEDLINE=96394464; PubMed=8798570; DOI=10.1074/jbc.271.38.23588;
RA   Stein E., Cerretti D.P., Daniel T.O.;
RT   "Ligand activation of ELK receptor tyrosine kinase promotes its
RT   association with Grb10 and Grb2 in vascular endothelial cells.";
RL   J. Biol. Chem. 271:23588-23593(1996).
RN   [8]
RP   INTERACTION WITH EPHB6.
RX   PubMed=11713248; DOI=10.1074/jbc.M108011200;
RA   Freywald A., Sharfe N., Roifman C.M.;
RT   "The kinase-null EphB6 receptor undergoes transphosphorylation in a
RT   complex with EphB1.";
RL   J. Biol. Chem. 277:3823-3828(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-968, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [10]
RP   STRUCTURE BY NMR OF 899-984.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the C-terminal SAM-domain of mouse ephrin type-
RT   B receptor 1 precursor (EC 2.7.1.112).";
RL   Submitted (JUL-2007) to the PDB data bank.
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-18; MET-387; THR-707; VAL-719;
RP   GLN-743; THR-912 AND MET-981.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-B family. Binds to
CC       ephrin-B1, -B2 and -B3. May be involved in cell-cell interactions
CC       in the nervous system.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: The ligand-activated form interacts with GRB2, GRB10 and
CC       NCK through their respective SH2 domains. The GRB10 SH2 domain
CC       binds EPHB1 through Tyr-928, while GRB2 binds residues within the
CC       catalytic domain. Interacts with EPHB6. The NCK SH2 domain binds
CC       EPHB1 through Tyr-594. Interacts with PRKCABP (By similarity).
CC   -!- INTERACTION:
CC       Q13322:GRB10; NbExp=1; IntAct=EBI-80252, EBI-80275;
CC       P62993:GRB2; NbExp=1; IntAct=EBI-80252, EBI-401755;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in brain.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB94627.1; Type=Miscellaneous discrepancy; Note=wrong intron-exon boundaries;
CC       Sequence=AAB94628.1; Type=Miscellaneous discrepancy; Note=wrong intron-exon boundaries;
CC       Sequence=AAD02031.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L40636; AAB08520.1; -; mRNA.
DR   EMBL; AF037331; AAD02030.1; -; mRNA.
DR   EMBL; AF037332; AAD02031.1; ALT_SEQ; mRNA.
DR   EMBL; AF037333; AAB94627.1; ALT_SEQ; mRNA.
DR   EMBL; AF037334; AAB94628.1; ALT_SEQ; mRNA.
DR   EMBL; AK291208; BAF83897.1; -; mRNA.
DR   EMBL; AC016931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016951; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC063918; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073244; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092969; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC111744; AAI11745.1; -; mRNA.
DR   IPI; IPI00008315; -.
DR   RefSeq; NP_004432.1; -.
DR   UniGene; Hs.116092; -.
DR   PDB; 2DJS; NMR; -; A=434-528.
DR   PDB; 2EAO; NMR; -; A=899-984.
DR   PDBsum; 2DJS; -.
DR   PDBsum; 2EAO; -.
DR   ProteinModelPortal; P54762; -.
DR   SMR; P54762; 18-197, 323-526, 592-889.
DR   IntAct; P54762; 9.
DR   STRING; P54762; -.
DR   PhosphoSite; P54762; -.
DR   PRIDE; P54762; -.
DR   Ensembl; ENST00000398015; ENSP00000381097; ENSG00000154928.
DR   GeneID; 2047; -.
DR   KEGG; hsa:2047; -.
DR   UCSC; uc003eqt.1; human.
DR   CTD; 2047; -.
DR   GeneCards; GC03P134316; -.
DR   H-InvDB; HIX0021414; -.
DR   HGNC; HGNC:3392; EPHB1.
DR   MIM; 600600; gene.
DR   PharmGKB; PA27824; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P54762; -.
DR   OMA; NSVACKA; -.
DR   OrthoDB; EOG9HB15Q; -.
DR   PhylomeDB; P54762; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; ephrinbrevpathway; Ephrin B reverse signaling.
DR   Pathway_Interaction_DB; ephrinb_ephbpathway; EphrinB-EPHB pathway.
DR   NextBio; 8321; -.
DR   PMAP-CutDB; P54762; -.
DR   ArrayExpress; P54762; -.
DR   Bgee; P54762; -.
DR   CleanEx; HS_EPHB1; -.
DR   Genevestigator; P54762; -.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020769; Tyr_prot_kinase_EphB_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF279; Tyr_prot_kinase_EphB_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     17
FT   CHAIN        18    984       Ephrin type-B receptor 1.
FT                                /FTId=PRO_0000016824.
FT   TOPO_DOM     18    540       Extracellular (Potential).
FT   TRANSMEM    541    563       Helical; (Potential).
FT   TOPO_DOM    564    984       Cytoplasmic (Potential).
FT   DOMAIN      323    424       Fibronectin type-III 1.
FT   DOMAIN      430    525       Fibronectin type-III 2.
FT   DOMAIN      619    882       Protein kinase.
FT   DOMAIN      911    975       SAM.
FT   NP_BIND     625    633       ATP (By similarity).
FT   MOTIF       982    984       PDZ-binding (Potential).
FT   COMPBIAS    183    319       Cys-rich.
FT   ACT_SITE    744    744       Proton acceptor (By similarity).
FT   BINDING     651    651       ATP (By similarity).
FT   MOD_RES     928    928       Phosphotyrosine.
FT   MOD_RES     968    968       Phosphoserine.
FT   CARBOHYD    334    334       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    426    426       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    480    480       N-linked (GlcNAc...) (Potential).
FT   VARIANT      18     18       M -> V (in dbSNP:rs55650774).
FT                                /FTId=VAR_042165.
FT   VARIANT      87     87       T -> S (in dbSNP:rs1042794).
FT                                /FTId=VAR_011801.
FT   VARIANT     152    152       G -> R (in dbSNP:rs1042793).
FT                                /FTId=VAR_011802.
FT   VARIANT     367    367       R -> G (in dbSNP:rs1042789).
FT                                /FTId=VAR_011803.
FT   VARIANT     387    387       T -> M (in dbSNP:rs56396912).
FT                                /FTId=VAR_042166.
FT   VARIANT     485    485       R -> S (in dbSNP:rs1042788).
FT                                /FTId=VAR_011804.
FT   VARIANT     707    707       S -> T (in an ovarian undifferentiated
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_042167.
FT   VARIANT     719    719       I -> V (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042168.
FT   VARIANT     743    743       R -> Q (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042169.
FT   VARIANT     847    847       M -> T (in dbSNP:rs1042785).
FT                                /FTId=VAR_011805.
FT   VARIANT     912    912       A -> T (in dbSNP:rs56345346).
FT                                /FTId=VAR_042170.
FT   VARIANT     973    973       R -> W (in dbSNP:rs1042784).
FT                                /FTId=VAR_058479.
FT   VARIANT     981    981       T -> M (in dbSNP:rs56186270).
FT                                /FTId=VAR_042171.
FT   MUTAGEN     928    928       Y->F: Disrupts binding with the GRB10 SH2
FT                                domain, providing evidence for
FT                                phosphorylation.
FT   CONFLICT     12     12       A -> E (in Ref. 2; AAD02030/AAB94627/
FT                                AAB94628).
FT   CONFLICT    185    185       S -> I (in Ref. 2; AAD02030/AAD02031/
FT                                AAB94627/AAB94628).
FT   CONFLICT    274    274       T -> R (in Ref. 2; AAD02030/AAD02031/
FT                                AAB94627/AAB94628).
FT   CONFLICT    336    336       T -> S (in Ref. 2; AAD02030/AAD02031/
FT                                AAB94627/AAB94628).
FT   CONFLICT    752    752       V -> L (in Ref. 5; AAI11745).
FT   CONFLICT    813    813       V -> H (in Ref. 2; AAD02030/AAB94627).
FT   CONFLICT    819    819       S -> Y (in Ref. 2; AAD02030/AAB94627).
FT   CONFLICT    881    881       M -> I (in Ref. 3; BAF83897).
FT   CONFLICT    903    903       L -> H (in Ref. 3; BAF83897).
FT   STRAND      441    445
FT   STRAND      447    453
FT   STRAND      464    473
FT   STRAND      482    495
FT   STRAND      501    512
FT   STRAND      514    517
FT   STRAND      521    524
FT   HELIX       916    921
FT   TURN        922    924
FT   HELIX       926    928
FT   HELIX       929    935
FT   HELIX       940    943
FT   HELIX       948    954
FT   HELIX       959    975
SQ   SEQUENCE   984 AA;  109885 MW;  8044160E24E93A92 CRC64;
     MALDYLLLLL LASAVAAMEE TLMDTRTATA ELGWTANPAS GWEEVSGYDE NLNTIRTYQV
     CNVFEPNQNN WLLTTFINRR GAHRIYTEMR FTVRDCSSLP NVPGSCKETF NLYYYETDSV
     IATKKSAFWS EAPYLKVDTI AADESFSQVD FGGRLMKVNT EVRSFGPLTR NGFYLAFQDY
     GACMSLLSVR VFFKKCPSIV QNFAVFPETM TGAESTSLVI ARGTCIPNAE EVDVPIKLYC
     NGDGEWMVPI GRCTCKPGYE PENSVACKAC PAGTFKASQE AEGCSHCPSN SRSPAEASPI
     CTCRTGYYRA DFDPPEVACT SVPSGPRNVI SIVNETSIIL EWHPPRETGG RDDVTYNIIC
     KKCRADRRSC SRCDDNVEFV PRQLGLTECR VSISSLWAHT PYTFDIQAIN GVSSKSPFPP
     QHVSVNITTN QAAPSTVPIM HQVSATMRSI TLSWPQPEQP NGIILDYEIR YYEKEHNEFN
     SSMARSQTNT ARIDGLRPGM VYVVQVRART VAGYGKFSGK MCFQTLTDDD YKSELREQLP
     LIAGSAAAGV VFVVSLVAIS IVCSRKRAYS KEAVYSDKLQ HYSTGRGSPG MKIYIDPFTY
     EDPNEAVREF AKEIDVSFVK IEEVIGAGEF GEVYKGRLKL PGKREIYVAI KTLKAGYSEK
     QRRDFLSEAS IMGQFDHPNI IRLEGVVTKS RPVMIITEFM ENGALDSFLR QNDGQFTVIQ
     LVGMLRGIAA GMKYLAEMNY VHRDLAARNI LVNSNLVCKV SDFGLSRYLQ DDTSDPTYTS
     SLGGKIPVRW TAPEAIAYRK FTSASDVWSY GIVMWEVMSF GERPYWDMSN QDVINAIEQD
     YRLPPPMDCP AALHQLMLDC WQKDRNSRPR FAEIVNTLDK MIRNPASLKT VATITAVPSQ
     PLLDRSIPDF TAFTTVDDWL SAIKMVQYRD SFLTAGFTSL QLVTQMTSED LLRIGITLAG
     HQKKILNSIH SMRVQISQSP TAMA
//
